Skip to main content
British Journal of Sports Medicine logoLink to British Journal of Sports Medicine
. 1978 Sep;12(3):125–128. doi: 10.1136/bjsm.12.3.125

Rock climbing: observations on heart rate and plasma catecholamine concentrations and the influence of oxprenolol.

E S Williams, P Taggart, M Carruthers
PMCID: PMC1859664  PMID: 719320

Abstract

Observations are presented on the electrocardiogram and plasma catecholamine concentrations of 11 healthy men monitored during two rock climbing ascents. A placebo was administered prior to the first climb and an oral dose of the beta blocking agent oxprenolol ("Trasicor") prior to the second. Mean heart rates were 166 (+/- 20.4 SD) and 120 (+/- 10.2) respectively. Median plasma adrenaline concentrations were 0.05 microgram/1 and 0.33 microgram/1 before and after the climbs following the placebo. No significant difference was observed in the adrenaline concentrations before and after climbing following oxprenolol, or of noradrenaline concentrations on either occasion. These results are interpreted as suggesting that this popular sport represents more an anxiety-type of psychological stress than a physical stress and as such is likely to increase moral fibre rather than muscle fibre.

Full text

PDF
125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carruthers M., Conway N., Somerville W., Taggart P., Bates D. Validity of plasma-catecholamine estimations. Lancet. 1970 Jul 11;1(7663):62–67. doi: 10.1016/s0140-6736(70)92638-3. [DOI] [PubMed] [Google Scholar]
  2. Imhof P. R., Blatter K., Fuccella L. M., Turri M. Beta-blockade and emotional tachycardia; radiotelemetric investigations in ski jumpers. J Appl Physiol. 1969 Sep;27(3):366–369. doi: 10.1152/jappl.1969.27.3.366. [DOI] [PubMed] [Google Scholar]
  3. James I. M., Griffith D. N., Pearson R. M., Newbury P. Effect of oxprenolol on stage-fright in musicians. Lancet. 1977 Nov 5;2(8045):952–954. doi: 10.1016/s0140-6736(77)90890-x. [DOI] [PubMed] [Google Scholar]
  4. Morris J. N., Chave S. P., Adam C., Sirey C., Epstein L., Sheehan D. J. Vigorous exercise in leisure-time and the incidence of coronary heart-disease. Lancet. 1973 Feb 17;1(7799):333–339. doi: 10.1016/s0140-6736(73)90128-1. [DOI] [PubMed] [Google Scholar]
  5. Taggart P., Carruthers M. Endogenous hyperlipidaemia induced by emotional stress of racing driving. Lancet. 1971 Feb 20;1(7695):363–366. doi: 10.1016/s0140-6736(71)92207-0. [DOI] [PubMed] [Google Scholar]
  6. Taggart P., Carruthers M., Somerville W. Electrocardiogram, plasma catecholamines and lipids, and their modification by oxyprenolol when speaking before an audience. Lancet. 1973 Aug 18;2(7825):341–346. doi: 10.1016/s0140-6736(73)93190-5. [DOI] [PubMed] [Google Scholar]
  7. Taggart P., Hedworth-Whitty R., Carruthers M., Gordon P. D. Observations on electrocardiogram and plasma catecholamines during dental procedures: the forgotten vagus. Br Med J. 1976 Oct 2;2(6039):787–789. doi: 10.1136/bmj.2.6039.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Taggart P., Parkinson P., Carruthers M. Cardiac responses to thermal, physical, and emotional stress. Br Med J. 1972 Jul 8;3(5818):71–76. doi: 10.1136/bmj.3.5818.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Turner R., Ball K. Prevention of coronary heart-disease. A counterblast to present inactivity. Lancet. 1973 Nov 17;2(7838):1137–1140. doi: 10.1016/s0140-6736(73)90948-3. [DOI] [PubMed] [Google Scholar]
  10. VON EULERU QUANTITATION OF STRESS BY CATECHOLAMINE ANALYSIS. Clin Pharmacol Ther. 1964 Jul-Aug;5:398–404. doi: 10.1002/cpt196454398. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Sports Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES